SIBO

Fibromyalgia and Small Intestinal Bacterial Overgrowth (SIBO)

Fibromyalgia is a condition in which there is pain all over the body, localized to the somatic muscles. This is experienced as soreness over certain points on pressure, in the form of a dull ache which has been present for at least 3 months at the time of diagnosis. The tenderness should be elicited over different points located over all the body quadrants.

Small Intestinal Bacterial Overgrowth (SIBO) Pathophysiology

Small Intestinal Bacterial Overgrowth Diagnosis

Fibromyalgia and Gut Health: SIBO and IBS

What Causes Small Intestinal Bacterial Overgrowth (SIBO)?

Rosacea and Small Intestinal Bacterial Overgrowth (SIBO)

Small Intestinal Bacterial Overgrowth (SIBO) Signs and Symptoms

Small Intestinal Bacterial Overgrowth (SIBO) Treatment

Risk Factors for Small Intestinal Bacterial Overgrowth

IBS and SIBO

What is SIBO?

Latest SIBO News and Research

Bedfont® Scientific Limited expands Middle East reach with Kuwaiti distributor

Bedfont® Scientific Limited, world leaders in breath analysis, is pleased to announce its collaboration with Medvision for Medical Services Company in Kuwait.

From Bedfont® Scientific Ltd 1 Jul 2025

Treating SIBO holistically helps patients feel better, new study finds

A 90-day real-world study in Spain shows that a comprehensive, personalized treatment for SIBO significantly improves patients’ quality of life—even when breath tests remain abnormal.

7 Apr 2025

Cedars-Sinai study investigates diet's role in treating gut disorders

A new study from Cedars-Sinai examined whether a specialized diet could improve symptoms of gastrointestinal disorders linked to an imbalance in gut microbiota.

1 Apr 2025

New study challenges traditional view of functional dyspepsia and gastroparesis

Functional dyspepsia (FD) and gastroparesis (GP) are gastrointestinal disorders often managed as separate conditions.

18 Mar 2025

Gastrolyzer® Range joins Selig De Colombia Portfolio, Expanding Access to Cutting-Edge Hydrogen Methane Breath Testing (HMBT) Technology

...

18 Feb 2025

Bedfont® Scientific Limited Brings Cutting-Edge Respiratory and Gastrointestinal Diagnostic Solutions to Saudi Arabia with New Registration

With the launch of NObreath® FeNO and Gastrolyzer® devices, Bedfont® and Tebaba Medical Services are advancing breath analysis technology in the Middle East.

From NObreath 3 Dec 2024

Nutrigenomics paves the way for customized diets in lactose intolerance care

The current evidence on omics tools that allow for developing tailored nutrition strategies for individuals with lactose intolerance (LI).

24 Jan 2024

Owlstone Medical launches OMED Health to enable patients to better understand their gut microbiome and manage their digestive health

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the launch of OMED Health, a dedicated, patient-centric brand and digital platform that will offer patients and clinicians access to breath-based diagnostic tests, point-of-care (PoC) devices and support resources for a range of conditions. Initially focused on digestive disease, OMED Health will help individuals with gut health issues have an improved quality of life by enabling better, and faster, understanding and management of their conditions.

From Owlstone Medical Ltd 4 Apr 2023

Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy

Owlstone Medical today announced the close of its Series D financing round.

From Owlstone Medical Ltd 7 Sep 2021

Bedfont Scientific Ltd. teams up with GI Cognition to launch Hydrogen and Methane Breath Testing ‘Home Kits’ to help improve Gastric Health remotely

Bedfont presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition.

From Bedfont® Scientific Ltd 10 Jun 2021

Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic

Owlstone Medical today announced agreements with Functional Gut Clinic ("FGC") and Functional Gut Diagnostics (“FGD”).

From Owlstone Medical Ltd 18 May 2021

SIBO

Overview

Small Intestinal Bacterial Overgrowth (SIBO) Pathophysiology

Small Intestinal Bacterial Overgrowth Diagnosis

Fibromyalgia and Gut Health: SIBO and IBS